Braun J - Search Results

1

High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort.

Poddubnyy D, Protopopov M, Haibel H, Braun J, Rudwaleit M, Sieper J. Poddubnyy D, et al. Among authors: braun j. Ann Rheum Dis. 2016 Dec;75(12):2114-2118. doi: 10.1136/annrheumdis-2016-209209. Epub 2016 Apr 28. Ann Rheum Dis. 2016. PMID: 27125522

2

Successful short term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-alpha monoclonal antibody infliximab.

Brandt J, Haibel H, Reddig J, Sieper J, Braun J. Brandt J, et al. Among authors: braun j. J Rheumatol. 2002 Jan;29(1):118-22. J Rheumatol. 2002. PMID: 11824947 Clinical Trial.

3

Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays.

Sieper J, Rudwaleit M, Braun J, van der Heijde D. Sieper J, et al. Among authors: braun j. Arthritis Rheum. 2002 Feb;46(2):319-27. doi: 10.1002/art.504. Arthritis Rheum. 2002. PMID: 11840434 Free article. Review. No abstract available.

4

Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.

Zou J, Rudwaleit M, Brandt J, Thiel A, Braun J, Sieper J. Zou J, et al. Among authors: braun j. Arthritis Rheum. 2003 Mar;48(3):780-90. doi: 10.1002/art.10847. Arthritis Rheum. 2003. PMID: 12632433 Free article.

5

Overview of the use of the anti-TNF agent infliximab in chronic inflammatory diseases.

Braun J, Sieper J. Braun J, et al. Expert Opin Biol Ther. 2003 Feb;3(1):141-68. doi: 10.1517/14712598.3.1.141. Expert Opin Biol Ther. 2003. PMID: 12718738 Review.

6

Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept.

Brandt J, Khariouzov A, Listing J, Haibel H, Sörensen H, Rudwaleit M, Sieper J, Braun J. Brandt J, et al. Among authors: braun j. J Rheumatol. 2004 Mar;31(3):531-8. J Rheumatol. 2004. PMID: 14994401 Clinical Trial.

7

An elevated level of IL-10- and TGFbeta-secreting T cells, B cells and macrophages in the synovial membrane of patients with reactive arthritis compared to rheumatoid arthritis.

Appel H, Neure L, Kuhne M, Braun J, Rudwaleit M, Sieper J. Appel H, et al. Among authors: braun j. Clin Rheumatol. 2004 Oct;23(5):435-40. doi: 10.1007/s10067-004-0916-5. Epub 2004 Jul 28. Clin Rheumatol. 2004. PMID: 15459815

8

Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).

van der Heijde D, Dijkmans B, Geusens P, Sieper J, DeWoody K, Williamson P, Braun J; Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group. van der Heijde D, et al. Among authors: braun j. Arthritis Rheum. 2005 Feb;52(2):582-91. doi: 10.1002/art.20852. Arthritis Rheum. 2005. PMID: 15692973 Free article. Clinical Trial.

9

Management and treatment of ankylosing spondylitis.

Zochling J, Braun J. Zochling J, et al. Among authors: braun j. Curr Opin Rheumatol. 2005 Jul;17(4):418-25. doi: 10.1097/01.bor.0000163194.48723.64. Curr Opin Rheumatol. 2005. PMID: 15956838 Review.

10

Anti-TNF agents for the treatment of spondyloarthropathies.

Sieper J, Braun J. Sieper J, et al. Among authors: braun j. Expert Opin Emerg Drugs. 2002 Oct;7(2):235-46. doi: 10.1517/14728214.7.2.235. Expert Opin Emerg Drugs. 2002. PMID: 15989547

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,474 results

Search Page